Insider filing · RNA

Troy Edward Wilson sold $4.3M of Avidity Biosciences (RNA)

Executed Aug 6 2025, disclosed Aug 8 2025, 2 days later.

Returns are measured on stock purchases only.

TW Troy Edward Wilson President and CEO profile →

Troy Edward Wilson (President and CEO) filed 3 Form 4 reports in the trailing twelve months (2 purchases, 1 sale), most often in Kura Oncology, Inc. (KURA). Across 1 priced purchase filing, the average 21-session return was +3.2% from execution and +3.2% from disclosure (delay-adjusted; derived). The largest single filing was $1.2M of KURA (100,000 sh × $12.39, as filed), executed Aug 24.

RNA RNA RNA · 61 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→